Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Aesthetic Plast Surg ; 47(5): 2130-2135, 2023 10.
Article in English | MEDLINE | ID: mdl-37500902

ABSTRACT

BACKGROUND: Facial feminization surgical procedures are involving several surgical disciplines in multiple surgical sites and therefore may carry the risk of developing infections. Data on the development of postsurgical infection (PSI) and contributing factors in male-to-female transgender people (transwomen) undergoing facial feminization surgery are scarce. The aim of this study was to investigate the contributing factors to develop PSIs in facial feminization surgical procedures. METHODS: Data from the medical records of 40 transwomen who underwent facial feminization surgeries in our institution between 2019 and 2021 were analyzed. The independent variables included demographic parameters (weight, body mass index, medical comorbidities and age), details of the surgical procedure (type, duration and whether another procedure had been performed concomitantly), type, dosage and route of administration of postoperative antibiotics and steroids, length of hospitalization and follow-up duration. Postsurgical infection was designated a dependent variable. RESULTS: Five out of 40 patients (12.5%) developed PSI. The surgery of those with PSIs involved more sites, and the duration of nasal tamponade was more than four times longer than for patients who did not develop a PSI. CONCLUSIONS: The current study revealed higher postsurgical infections rates after lengthy surgeries or when it involves several surgical facial feminization procedures. Multicenter clinical trial on a big cohort may enable better evidence-based results. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .


Subject(s)
Face , Feminization , Humans , Male , Female , Feminization/epidemiology , Face/surgery , Risk Factors , Treatment Outcome
2.
Environ Health Perspect ; 119(3): 306-11, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21362587

ABSTRACT

BACKGROUND: The feminization of nature by endocrine-disrupting chemicals (EDCs) is a key environmental issue affecting both terrestrial and aquatic wildlife. A crucial and as yet unanswered question is whether EDCs have adverse impacts on the sustainability of wildlife populations. There is widespread concern that intersex fish are reproductively compromised, with potential population-level consequences. However, to date, only in vitro sperm quality data are available in support of this hypothesis. OBJECTIVE: The aim of this study was to examine whether wild endocrine-disrupted fish can compete successfully in a realistic breeding scenario. METHODS: In two competitive breeding experiments using wild roach (Rutilus rutilus), we used DNA microsatellites to assign parentage and thus determine reproductive success of the adults. RESULTS: In both studies, the majority of intersex fish were able to breed, albeit with varying degrees of success. In the first study, where most intersex fish were only mildly feminized, body length was the only factor correlated with reproductive success. In the second study, which included a higher number of more severely intersex fish, reproductive performance was negatively correlated with severity of intersex. The intersex condition reduced reproductive performance by up to 76% for the most feminized individuals in this study, demonstrating a significant adverse effect of intersex on reproductive performance. CONCLUSION: Feminization of male fish is likely to be an important determinant of reproductive performance in rivers where there is a high prevalence of moderately to severely feminized males.


Subject(s)
Cyprinidae/physiology , Endocrine Disruptors/toxicity , Feminization/epidemiology , Reproduction/drug effects , Water Pollutants, Chemical/toxicity , Animals , Competitive Behavior , Male , Population Dynamics , Spermatozoa/drug effects , Testis/drug effects
3.
Rio de Janeiro; s.n; 2011. 130f p. ilus.
Thesis in Portuguese | LILACS | ID: lil-616817

ABSTRACT

A epidemia de HIV/AIDS, pelo seu histórico, é de natureza mutável em vários contextos sociais em todo o mundo. Desde a notificação dos primeiros casos até hoje, observa-se um curso diferenciado no decorrer do tempo, tanto no campo social como na biomedicina, o que a torna um problema passível de controle a longo prazo. Essas mudanças, entretanto, não são percebidas de igual maneira em todos os países ou regiões. Devido a vários fatores, a epidemia persiste como uma das dez primeiras causas de morte no mundo, sendo a primeira delas na África. No Brasil, o perfil da epidemia assemelha-se ao global, tendendo a diminuir/estabilizar a velocidade do surgimento de novos casos. Essa contenção deve-se ao impacto de ações preventivas desenvolvidas por iniciativas governamentais e não governamentais no sentido de promover práticas sexuais mais seguras. Neste mesmo contexto, algumas análises espaciais revelam transições demográficas da epidemia de HIV/AIDS nos anos mais recentes. Há mudanças e desigualdades na razão de sexo em diferentes condições sociodemográficas e do ponto de vista geracional. Em razão disso, este trabalho justifica-se pela necessidade de analisar as mudanças na razão de sexo, fornecendo informações importantes para o planejamento e política de prevenção no tratamento da AIDS, tendo em vista a vulnerabilidade da população feminina. O objetivo principal desta pesquisa é analisar diferenças históricas, espaciais e sociais da razão de sexo e idade na população internada pelo SUS em consequência da infecção pelo HIV no período de 1998 a 2009. estrato com dados do censo de 2000...


Subject(s)
Humans , Feminization/epidemiology , Health Profile , Heterosexuality , HIV , Acquired Immunodeficiency Syndrome/epidemiology , Cultural Characteristics
5.
Environ Health Perspect ; 114 Suppl 1: 134-41, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16818259

ABSTRACT

Atrazine is a potent endocrine disruptor that both chemically castrates and feminizes male amphibians. It depletes androgens in adult frogs and reduces androgen-dependent growth of the larynx in developing male larvae. It also disrupts normal gonadal development and feminizes the gonads of developing males. Gonadal malformations induced by atrazine include hermaphrodites and males with multiple testes [single sex polygonadism (SSP)], and effects occur at concentrations as low as 0.1 ppb (microg/L). Here, we describe the frequencies at which these malformations occur and compare them with morphologies induced by the estrogen, 17beta-estradiol (E2) , and the antiandrogen cyproterone acetate, as a first step in testing the hypothesis that the effects of atrazine are a combination of demasculinization and feminization. The various forms of hermaphroditism did not occur in controls. Nonpigmented ovaries, which occurred at relatively high frequencies in atrazine-treated larvae, were found in four individuals out of more than 400 controls examined (1%). Further, we show that several types of gonadal malformations (SSP and three forms of hermaphroditism) are produced by E2 exposure during gonadal differentiation, whereas a final morphology (nonpigmented ovaries) appears to be the result of chemical castration (disruption of androgen synthesis and/or activity) by atrazine. These experimental findings suggest that atrazine-induced gonadal malformations result from the depletion of androgens and production of estrogens, perhaps subsequent to the induction of aromatase by atrazine, a mechanism established in fish, amphibians, reptiles, and mammals (rodents and humans).


Subject(s)
Atrazine/toxicity , Cyproterone Acetate/pharmacology , Estradiol/pharmacology , Feminization/chemically induced , Gonads/abnormalities , Xenopus laevis/abnormalities , Androgen Antagonists/pharmacology , Animals , Cross-Sectional Studies , Disorders of Sex Development/chemically induced , Disorders of Sex Development/pathology , Female , Feminization/epidemiology , Gonads/drug effects , Male , Metamorphosis, Biological/drug effects , Models, Biological , Sex Differentiation/drug effects , Sex Differentiation/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...